From the Fourth Department of Internal Medicine, Silesian University School of medicine, ul. Edukacji 102, pl 43- 100 Tychy, Poland.
Abstract: (3886 Views)
A three-fold decrease of the in vitro ability of serum proteins to bind naproxen
was shown in patients with cirrhosis of the liver compared to healthy individuals.
This decrease was caused by quantitative changes in serum proteins in the sera of
patients with liver damage. Lower doses of naproxen are therefore suggested in the
treatment of patients with liver dysfunction.